Table 2.
Treatment administered to patients with recurrent pancreatic ductal adenocarcinoma
Characteristics | Number = 140 (%) |
---|---|
Chemotherapy for rPDAC | |
Single Agent | 19 (13) |
Non-Standard Combination | 47 (34) |
Standard Combination | 74 (53) |
Lines of chemotherapy for rPDAC | |
1 | 73 (52) |
2 | 47 (34) |
3 | 15 (11) |
4–6 | 5 (3) |
rPDAC: recurrent pancreatic ductal adenocarcinoma